Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip

Inclusion Criteria:

- Is male or female ≥ 40 years of age

- If a participant in the previous MEL3-12-02 study, completed the study and did not
discontinue for lack of efficacy or safety

- Has a diagnosis of OA of the hip or knee with ongoing knee and/or articular hip pain

- Chronic user of nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acetaminophen
for OA pain

- If female and of childbearing potential, is nonlactating and nonpregnant

Exclusion Criteria:

- History of allergic reaction or clinically significant intolerance to acetaminophen,
aspirin, or any NSAIDs, including meloxicam

- Requires continuous use of opioid or opioid combination products to control OA pain
of the knee or hip

- Clinically significant unstable cardiac, respiratory, neurological, immunological,
hematological, or renal disease

- Significant difficulties swallowing capsules or unable to tolerate oral medication

- Has received any investigational drug (ecept Meloxicam SoluMatrix Capsules), device,
or therapy within 30 days before Screening